Tai Phat Huynh

Title: The Innovative Contributions of Tai Phat Huynh

Introduction

Tai Phat Huynh is a prominent inventor based in Oakland, California. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate protein kinase enzymatic activity. With a total of 14 patents to his name, Huynh's work has the potential to impact various cellular activities and therapeutic applications.

Latest Patents

One of Huynh's latest patents focuses on C-met modulators and methods of use. This invention provides compounds designed to modulate protein kinase enzymatic activity, which in turn influences cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. Specifically, the invention includes quinazolines and quinolines that inhibit, regulate, and/or modulate kinase receptors, particularly c-Met, KDR, c-Kit, flt-3, and flt-4. These compounds are crucial for treating kinase-dependent diseases and conditions. Additionally, the patent outlines methods for synthesizing these compounds and the compositions that contain them.

Career Highlights

Throughout his career, Tai Phat Huynh has worked with notable companies in the biotechnology sector, including Exelixis, Inc. and Exelixis Patent Company LLC. His experience in these organizations has allowed him to refine his expertise in the development of innovative therapeutic solutions.

Collaborations

Huynh has collaborated with several professionals in his field, including James William Leahy and Jeff Z Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Tai Phat Huynh's innovative work in the field of biotechnology, particularly in the area of protein kinase modulation, showcases his significant contributions to medical science. His patents and collaborations reflect a commitment to advancing therapeutic options for various diseases.